Lee Willis C's Form 4 filing
Emmaus Life Sciences, Inc. (EMMA) · filed Feb 29, 2024
- Accession no.
- 0001209191-24-004124
- Filed
- Feb 29, 2024, 6:11 PM ET
- Trade date
- Feb 26-29, 2024
- Filing delay
- 3 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market purchases total $14.7K. It was filed 3 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lee Willis CCIK 0001517775 | Director, Officer (Co-President & COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 26, 2024 | Common stock, $0.001 par value | PPurchaseAcquired | +13,200 | $0.12 | +$1,584 | 57,400 | Indirect | |
| Feb 27, 2024 | Common stock, $0.001 par value | PPurchaseAcquired | +10,000 | $0.13 | +$1,300 | 67,400 | Indirect | |
| Feb 28, 2024 | Common stock, $0.001 par value | PPurchaseAcquired | +15,000 | $0.12 | +$1,800 | 82,400 | Indirect | |
| Feb 29, 2024 | Common stock, $0.001 par value | PPurchaseAcquired | +77,000 | $0.13 | +$10,010 | 159,400 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.